Search

Displaying results 8851 - 8860 of 10000 in total
  1. Drug

    Moxaverine

    go.drugbank.com/drugs/DB12251
    Investigational

    Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

    Categories: Heterocyclic Compounds, 2-Ring
  2. Drug

    Platinum

    go.drugbank.com/drugs/DB12257
    Investigational

    Platinum is under investigation for the treatment of Metastatic Breast Cancer, Non-small Cell Lung Cancer, Gastric Large Cell Neuroendocrine Carcinoma, Colorectal Large Cell Neuroendocrine Carcinoma, and

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    ORE-1001

    go.drugbank.com/drugs/DB12271
    Investigational

    It is an ACE2 inhibitor.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Ecopipam

    go.drugbank.com/drugs/DB12273
    Investigational

    Ecopipam has been used in trials studying the treatment of Tourette's Syndrome, Lesch-Nyhan Disease, Pathological Gambling, and Self-injurious Behavior.

    Categories: Heterocyclic Compounds, 2-Ring
  6. Drug

    Seviteronel

    go.drugbank.com/drugs/DB12275
    Investigational

    Seviteronel has been used in trials studying the treatment of CRPC, Prostate Cancer, and Castration-resistant Prostate Cancer.

    Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 Enzyme Inhibitors
  7. Drug

    Luspatercept

    go.drugbank.com/drugs/DB12281
    ApprovedInvestigational

    Luspatercept is a recombinant fusion protein comprised of a modified extracellular domain of activin receptor type IIB fused to the FC domain of human IgG1. … [A187835] Luspatercept's novel mechanism of action, then, is uniquely suited for the treatment of conditions in which late-stage erythropoiesis is defective, such as beta thalassemia and other myelodysplastic

    Products: REBLOZYL®
  8. Drug

    Defactinib

    go.drugbank.com/drugs/DB12282
    ApprovedInvestigational

    Defactinib is a small molecule kinase inhibitor targeted against focal adhesion kinase (FAK) and proline-rich tyrosine kinase-2 (Pyk2), the two members of the FAK family of nonreceptor tyrosine kinases … [L53198,L53208] FAK is important for the integrin-mediated activation of several downstream signal transduction pathways, including those involving RAS/MEK/ERK and PI3K/Akt, and its upregulation is a key

    Synonyms: N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamideCategories: MATE 2 Inhibitors, Cytochrome P-450 Substrates
  9. Drug

    Balapiravir

    go.drugbank.com/drugs/DB12283
    Investigational

    Balapiravir has been used in trials studying the treatment of Dengue and Hepatitis C, Chronic.

  10. Drug

    LY-2608204

    go.drugbank.com/drugs/DB12284
    Investigational

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

    Categories: Heterocyclic Compounds, 1-Ring